RASTRUM
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

RASTRUM Trademark

Serial Number: 79346809 • Registration: 7178495

RASTRUM is a trademark filed by Inventia Life Science Pty Ltd on February 7, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Inventia Life Science Pty Ltd (3 trademarks)

7 Hunter St WATERLOO NSW 2017

Entity Type: 99

Trademark Details

Filing Date

February 7, 2022

Registration Date

October 3, 2023

Published for Opposition

July 18, 2023

Goods & Services

Data management, namely database management; retail and wholesale store services for pharmaceutical, medical, scientific, laboratory and 3D printing consumables and supplies; administrative processing of purchase orders; computerised procurement services, namely, procurement of pharmaceutical and medical supplies for others, namely ordering and purchasing pharmaceutical and medical supplies for others; computerised data processing; compilation of scientific information into databases; business administration in the nature of maintenance of registers for others, including registers relating to device history and maintenance history

Surgical biological tissue grafts; engineered biological living tissues and 3d cell cultures for medical and surgical use; tissue-regenerative medical preparations for generating skin cells, tissues and organs; biological tissue cultures for medical purposes

Scientific and research apparatus and instruments for use in the fields of life science research, biomedicine and bioprinting, namely, laboratory robots; downloadable software for monitoring and controlling communication between computers and automated machine systems; downloadable software for operating and controlling 3D printers, downloadable operating software to control laboratory apparatus for fabrication of 3D engineered living tissues and 3D cell cultures; downloadable software for the purpose of the manufacture of products by means of a 3D printer, including medical products; computer peripherals; laboratory instruments and apparatus, namely cell assembly apparatus for laboratory use for fabrication of 3D engineered living tissues and 3D cell cultures; downloadable electronic publications, namely pamphlets, brochures, journals, books, manuals, newsletters and booklets in the field of biomedical research, 3D printing, cell printing, cell assembly, drug discovery and disease research; recorded and downloadable media, namely audio and video recordings and downloadable audio and video files containing digital matrices and 3-dimensional cell model templates; parts and fittings for all of the foregoing, namely electronic control panels with digital displays for the control of 3D printers, printer cables, and ink cartridges, unfilled, for printers

Industrial analysis and research in the field of bioprinting, 3D printing, drug discovery, biomedicine and disease research; industrial design; design and development of computer software; software-as-a-service featuring software for use in the field of biomedical research, drug discovery and disease research to design and control experiments, to identify, select and print biomaterials for the purpose of experiments, and to clean and maintain bioprinters and 3D printers; platform-as-a-service featuring software for use in the field of biomedical research, drug discovery and disease research to design and control experiments, to identify, select and print biomaterials for the purpose of experiments, and to clean and maintain bioprinters and 3D printers; providing online non-downloadable software featuring software for use in the field of biomedical research, drug discovery and disease research to design and control experiments, to identify, select and print biomaterials for the purpose of experiments, and to clean and maintain bioprinters and 3D printers.; computer programming; installation, repair and maintenance of computer software; analysis of statistical data for scientific research; design of software; design of biological materials; design services relating to printing and product design, including design of models and matrices for use in 3-dimensional printing; research relating to design; laboratory research in the field of bioprinting and the creation and engineering of 3D cells and living tissues; biomedical research; cloud computing featuring software for use in the field of biomedical research, drug discovery and disease research to design and control experiments, to identify, select and print biomaterials for the purpose of experiments, and to clean and maintain bioprinters and 3D printers.; technical advisory services relating to scientific products and scientific research; scientific research into the development of new products; engineering services, including hydrogel engineering, and 3D cell culture engineering and tissue engineering; providing technical support services, namely technical advice regarding medical and diagnostic laboratory instruments and systems; providing online non-downloadable web-based software platform for laboratory and diagnostic equipment information management, monitoring and analysis; providing information, including online, about all of the foregoing

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Aug 6, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Aug 30, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Aug 23, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 30, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 8, 2024 FICS
FINAL DISPOSITION PROCESSED
Jan 8, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 3, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 3, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 3, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 18, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 18, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 28, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 14, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 5, 2023 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 1, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 1, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 1, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 1, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 1, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 1, 2023 COAR
REFUSAL PROCESSED BY IB
Jan 5, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 10, 2022 RFCS
REFUSAL PROCESSED BY MPU
Dec 10, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 29, 2022 RFCR
NON-FINAL ACTION WRITTEN
Sep 28, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 28, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 9, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 5, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 4, 2022 REPR